Isosorbide and Hydralazine BIDIL
Description
Bidil, also known as isosorbide dinitrate/hydralazine, is a combination medication used to treat heart failure in African Americans. It was the first drug approved by the FDA specifically for a racial group, sparking controversy regarding its efficacy and ethical implications. Bidil works by relaxing blood vessels, reducing the workload on the heart and improving blood flow. However, its use has been met with mixed reactions, with some arguing for its benefits in specific populations while others question its general effectiveness and raise concerns about potential racial bias in healthcare.
Associated Diseases
Did you know?
Bidil was originally developed as a treatment for angina but was later found to be more effective in African Americans with heart failure.
